IL72536A - Highly pure crystalline cefuroxime 1-acetoxyethyl ester and preparation thereof - Google Patents

Highly pure crystalline cefuroxime 1-acetoxyethyl ester and preparation thereof

Info

Publication number
IL72536A
IL72536A IL72536A IL7253684A IL72536A IL 72536 A IL72536 A IL 72536A IL 72536 A IL72536 A IL 72536A IL 7253684 A IL7253684 A IL 7253684A IL 72536 A IL72536 A IL 72536A
Authority
IL
Israel
Prior art keywords
preparation
highly pure
pure crystalline
acetoxyethyl ester
crystalline cefuroxime
Prior art date
Application number
IL72536A
Other versions
IL72536A0 (en
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IL72536A0 publication Critical patent/IL72536A0/en
Publication of IL72536A publication Critical patent/IL72536A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL72536A 1983-07-29 1984-07-29 Highly pure crystalline cefuroxime 1-acetoxyethyl ester and preparation thereof IL72536A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838320521A GB8320521D0 (en) 1983-07-29 1983-07-29 Chemical process

Publications (2)

Publication Number Publication Date
IL72536A0 IL72536A0 (en) 1984-11-30
IL72536A true IL72536A (en) 1988-01-31

Family

ID=10546505

Family Applications (1)

Application Number Title Priority Date Filing Date
IL72536A IL72536A (en) 1983-07-29 1984-07-29 Highly pure crystalline cefuroxime 1-acetoxyethyl ester and preparation thereof

Country Status (21)

Country Link
JP (1) JPH0613526B2 (en)
KR (1) KR910008377B1 (en)
AT (1) AT392470B (en)
AU (2) AU582121B2 (en)
BE (1) BE900241A (en)
CA (1) CA1265511A (en)
CH (1) CH662121A5 (en)
DE (1) DE3427828A1 (en)
DK (1) DK165505C (en)
ES (1) ES8601869A1 (en)
FI (1) FI76808C (en)
FR (1) FR2549837B1 (en)
GB (2) GB8320521D0 (en)
IE (1) IE57726B1 (en)
IL (1) IL72536A (en)
NL (1) NL8402372A (en)
NO (1) NO167292C (en)
NZ (1) NZ209046A (en)
PT (1) PT78985B (en)
SE (1) SE463263B (en)
ZA (1) ZA845830B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8400024D0 (en) * 1984-01-03 1984-02-08 Glaxo Group Ltd Cephalosporin antibiotics
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
US5063224A (en) * 1990-07-09 1991-11-05 Eli Lilly And Company R-cefuroxime axetil
IT1277426B1 (en) * 1995-08-03 1997-11-10 Acs Dobfar Spa BIOAVAILABLE CRYSTALLINE FORM OF CEFUROXIMA AXETIL
CN1111537C (en) * 1997-05-15 2003-06-18 第一制糖株式会社 The preparation method of highly pure crystalline form of cefuroxime axetil
KR100228264B1 (en) * 1997-08-02 1999-11-01 김선진 The synthetic method of crystalline cefuroxime axetil
CA2209868C (en) * 1997-08-15 2001-08-14 Bernard Charles Sherman Pharmaceutical compositions comprising cefuroxime axetil
IN186539B (en) * 1997-09-29 2001-09-29 Ranbaxy Lab Ltd
ES2171056T3 (en) * 1998-02-20 2002-08-16 Fako Ilaclari A S PROCEDURE FOR THE MANUFACTURE OF SOLUBLE CRYSTALLINE AXETIL CEFUROXIMA.
IN190849B (en) 2000-07-17 2003-08-23 Ranbaxy Lab Ltd
AT411996B (en) 2000-09-11 2004-08-26 Sandoz Ag METHOD FOR PRODUCING CEFUROXIME IN THE FORM OF ITS N-BUTYL LAMONIUM SALTS
ITMI20011763A1 (en) * 2001-08-10 2003-02-10 Antibioticos Spa HIGH-PURITY CEFUROXIME AXELITE PREPARATION PROCESS
ITMI20011925A1 (en) * 2001-09-14 2003-03-14 Antibioticos Spa METHOD APPLICABLE ON INDUSTRIAL SCALE FOR THE PREPARATION OF CEFUROXIME AXETILE CRISTALLINO
TWI328006B (en) * 2003-12-26 2010-08-01 Nissan Chemical Ind Ltd Crystal form of quinoline compound and process for its production
CN100448879C (en) * 2004-07-22 2009-01-07 北京化工大学 Method for preparing unformed cefuroxime axetil
DE102005019458A1 (en) 2005-04-25 2006-10-26 Grünenthal GmbH Composition, useful in the preparation of pellets and the multi-particular-presentation form, comprises cefuroximaxetil and carrageenan of the group of lambda carrageenan, tau carrageenan and kappa carrageenan

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1571683A (en) * 1976-02-16 1980-07-16 Glaxo Operations Ltd Ester derivatives of cefuroxime
CA1094545A (en) * 1976-02-16 1981-01-27 Michael Gregson Cephalosporin antibiotics
GB1598568A (en) * 1977-04-19 1981-09-23 Glaxo Lab Ltd Esters of(6r,7r)-3-carbamoyloxymethyl-7-((z)-2-(fur-2-yl)-2-methoxyiminoacetamido)-ceph-3-em-4-carboxylic acid
JPS577485A (en) * 1980-06-13 1982-01-14 Takeda Chem Ind Ltd Cephalosporin
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
GB8400024D0 (en) * 1984-01-03 1984-02-08 Glaxo Group Ltd Cephalosporin antibiotics

Also Published As

Publication number Publication date
DE3427828A1 (en) 1985-02-14
AU582121B2 (en) 1989-03-16
FR2549837A1 (en) 1985-02-01
SE8403897L (en) 1985-01-30
GB8419202D0 (en) 1984-08-30
FI76808B (en) 1988-08-31
IL72536A0 (en) 1984-11-30
AU3660189A (en) 1989-10-05
AT392470B (en) 1991-04-10
NL8402372A (en) 1985-02-18
KR910008377B1 (en) 1991-10-12
ATA244484A (en) 1990-09-15
FI843011A0 (en) 1984-07-27
FI76808C (en) 1988-12-12
ZA845830B (en) 1986-03-26
KR850001221A (en) 1985-03-16
CH662121A5 (en) 1987-09-15
NO167292B (en) 1991-07-15
CA1265511A (en) 1990-02-06
JPH0613526B2 (en) 1994-02-23
SE463263B (en) 1990-10-29
DK366684D0 (en) 1984-07-27
ES534695A0 (en) 1985-11-01
NZ209046A (en) 1988-02-29
PT78985A (en) 1984-08-01
JPS6075484A (en) 1985-04-27
GB2145409A (en) 1985-03-27
AU634965B2 (en) 1993-03-11
IE57726B1 (en) 1993-03-24
NO167292C (en) 1991-10-23
AU3125684A (en) 1985-01-31
NO843055L (en) 1985-01-30
GB2145409B (en) 1987-02-18
DK165505C (en) 1993-04-19
DK366684A (en) 1985-01-30
IE841938L (en) 1985-01-29
FR2549837B1 (en) 1986-12-26
SE8403897D0 (en) 1984-07-27
BE900241A (en) 1985-01-28
ES8601869A1 (en) 1985-11-01
PT78985B (en) 1986-10-23
FI843011A (en) 1985-01-30
GB8320521D0 (en) 1983-09-01
DK165505B (en) 1992-12-07

Similar Documents

Publication Publication Date Title
GB8320518D0 (en) Cefuroxime ester
IL72536A (en) Highly pure crystalline cefuroxime 1-acetoxyethyl ester and preparation thereof
AU566161B2 (en) Crystalline silicas
GB8520479D0 (en) Crystalline esters
AU2920084A (en) Crystalline gallo-silicates
AU571619B2 (en) Crystalline silicophosphoaluminate
IL84580A0 (en) Novel cephalosporin derivatives and their crystalline derivatives
ZA843224B (en) Substituted cephalosporins as anti-inflammatory and antidegenerative agents
HK42595A (en) Crystalline cephalosporin antibiotics
AU2646784A (en) Crystalline zincosilicate
AU570084B2 (en) Crystalline silicas
AU566096B2 (en) Cephalosporin ester derivatives
EP0141319A3 (en) Substituted phenoxyalcanoic-acid ester
AU579597B2 (en) Crystalline silicophosphoaluminate
AU2993184A (en) Crystalline polyphosphides
EP0146390A3 (en) Crystalline silicophosphoaluminate
AU2591984A (en) Ester of tricyclohexyl-tin hydroxide
AU3252284A (en) Polyarylate composition
AU568174B2 (en) Crystalline silicophosphoaluminate
ZA849732B (en) Crystalline silicophosphoaluminate
GB8400450D0 (en) Cephalosporins preparation
PH18429A (en) Crystalline cephalosporin
ZA842775B (en) New crystalline modification of ceftazidim
AU571040B2 (en) Crystalline silicophosphoaluminates
AU571041B2 (en) Crystalline silicophosphoaluminate

Legal Events

Date Code Title Description
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees